Cipla Limited (CIPLA.BO)
Cipla Limited, manufactures, develops, sells, and distributes pharmaceutical products in India, the United States, South Africa, and internationally.
1,466.00-0.01%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago+3.4%
The outlook
Cipla Limited currently reads as neutral based on hold — 2.6 avg of 36 analysts, mixed vs its moving averages, 47% of the way from its 52-week low to high, avg target -1% vs current price. This is a snapshot of current market data, not a forecast.
What’s behind the score
Analyst consensusHold — 2.6 avg of 36 analysts
Price trendMixed vs its moving averages
52-week range47% of the way from its 52-week low to high
Price targetAvg target -1% vs current price
Analyst price target
~12-month · 36 analysts1,458.53average target-0.5% vs now
Now 1,466.00
Low 1,170.00High 1,827.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$1.18T
52-wk high
1,672.20
52-wk low
1,283.00
50-day avg
1,456.22
200-day avg
1,507.22
Trailing P/E
26.1